CIPOLLINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.854
EU - Europa 1.134
AS - Asia 1.115
SA - Sud America 167
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.319
Nazione #
US - Stati Uniti d'America 2.802
IT - Italia 426
SG - Singapore 389
CN - Cina 338
DE - Germania 191
HK - Hong Kong 156
BR - Brasile 148
SE - Svezia 123
GB - Regno Unito 84
BG - Bulgaria 71
VN - Vietnam 67
RU - Federazione Russa 55
FI - Finlandia 45
CA - Canada 40
IN - India 39
TR - Turchia 35
KR - Corea 28
EE - Estonia 24
UA - Ucraina 21
CI - Costa d'Avorio 19
FR - Francia 19
BE - Belgio 13
PL - Polonia 13
JP - Giappone 10
NL - Olanda 10
AR - Argentina 9
IQ - Iraq 9
AT - Austria 8
BD - Bangladesh 8
MX - Messico 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
MA - Marocco 6
PK - Pakistan 6
ES - Italia 5
ID - Indonesia 5
SA - Arabia Saudita 5
SN - Senegal 5
DZ - Algeria 4
LT - Lituania 4
UZ - Uzbekistan 4
EC - Ecuador 3
OM - Oman 3
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
GA - Gabon 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
KG - Kirghizistan 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.319
Città #
Ashburn 323
Fairfield 288
Woodbridge 273
Dallas 243
Ann Arbor 215
Houston 202
Singapore 191
Chandler 156
Hong Kong 154
Santa Clara 145
Seattle 135
Serra 135
Cambridge 115
Beijing 80
Wilmington 72
Sofia 70
Shanghai 66
Milan 63
New York 57
Boardman 50
Pisa 38
Princeton 36
Hefei 34
Munich 32
Los Angeles 31
Ottawa 30
Medford 27
London 26
Frankfurt am Main 25
Lawrence 24
Seoul 22
Abidjan 19
Des Moines 19
Florence 19
Dong Ket 18
Genoa 17
Ho Chi Minh City 14
Istanbul 14
Nanjing 14
Brussels 13
Buffalo 12
Lucca 12
Phoenix 12
Izmir 11
Lancaster 11
Jacksonville 10
Lappeenranta 10
Livorno 10
Redondo Beach 10
San Diego 10
Columbus 9
Dearborn 9
Nürnberg 9
Tokyo 9
Warsaw 9
Council Bluffs 8
Helsinki 8
Nettuno 8
San Jose 8
São Paulo 8
The Dalles 8
Turku 8
Fuzhou 7
Nanchang 7
San Francisco 7
Viareggio 7
Bremen 6
Brooklyn 6
Daejeon 6
Guangzhou 6
Pune 6
Rome 6
Shenyang 6
Vienna 6
Belo Horizonte 5
Bern 5
Casablanca 5
Dakar 5
Ogden 5
Redwood City 5
Stockholm 5
Washington 5
Ankara 4
Boulder 4
Changsha 4
Chennai 4
Düsseldorf 4
Falkenstein 4
Hanoi 4
Hyderabad 4
Islamabad 4
Nuremberg 4
Orangeburg 4
Orem 4
Poplar 4
Rio de Janeiro 4
Augusta 3
Camden 3
Chengdu 3
Falls Church 3
Totale 3.898
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 320
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 280
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 255
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 233
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 231
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 217
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 208
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 206
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 200
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 188
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. 186
Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review. 186
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 183
Inherited variants in genes somatically mutated in thyroid cancer 182
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. 180
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 178
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma 176
Genome-wide association study on differentiated thyroid cancer. 169
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans 167
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism 166
Correction: Inherited variants in genes somatically mutated in thyroid cancer 162
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk 158
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system 152
High prevalence of chromosome 10 rearrangements in human lymphocytes after in vitro X-ray irradiation 141
Runs of homozygosity and inbreeding in thyroid cancer 132
MicroRNA binding site polymorphisms as biomarkers in cancer management and research. 130
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 130
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 115
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 112
Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide 105
null 17
Totale 5.465
Categoria #
all - tutte 14.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 14 21 22 42 23 26 78
2021/2022354 14 37 12 15 64 44 14 18 17 10 17 92
2022/2023472 44 78 29 43 42 66 3 43 77 3 41 3
2023/2024371 55 30 74 16 33 59 12 18 2 15 26 31
2024/20251.222 2 38 15 97 120 119 129 63 103 156 136 244
2025/2026894 138 194 198 104 145 115 0 0 0 0 0 0
Totale 5.465